However, loss of p70S6K activity with combined loss of the mTORC2 substrate Akt2 results in defects in both insulin action and β-cell function, suggesting that both mTOR components are required to maintain insulin signaling and prevent DM [227]. The gene discussed is RPS6KB1; the disease is diabetes mellitus.